172895-39-5Relevant academic research and scientific papers
Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
-
, (2008/06/13)
This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a 5-HT 2 antagonist.
Methods of treating or ameliorating the symptoms of venomous bites and stings
-
, (2008/06/13)
This invention provides a method for the treatment or amelioration of the symptoms of venomous bites or stings which comprises administering to a mammal in need thereof one or more 5-HT 2 antagonists.
METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS
-
, (2008/06/13)
The present invention provides methods for binding a 5-HT 2B receptor in mammals using a both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT 2B related conditions. Finally, the invention provides an article of manufacture.
Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
-
, (2008/06/13)
This invention provides a method for the treatment or amelioration of the symptoms of venomous bites or stings which comprises administering to a mammal in need thereof one or more 5-HT2antagonists.
Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
-
, (2008/06/13)
This invention provides methods for the treatment or amelioration of the symptoms of the common cold or allergic rhinitis which comprises administering to a mammal in need thereof a 5-HT2antagonist.
INTERMEDIATES TO TETRAHYDRO-BETA-CARBOLINES
-
, (2008/06/13)
3-Ethanamine and 3-ethanamine related compounds are provided that are useful intermediates and have beneficial central nervous system activity.
Tetrahydro-β-carbolines
-
, (2008/06/13)
The present invention provides tetrahydro-betacarboline compounds having useful central nervous system activity.
